Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.800.811.131.321.16

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.80 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.80
Mar20240.81
Mar20231.13
Mar20221.32
Mar20211.16

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.8
-1.23
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32
13.79
Mar2021 1.16 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,131.8 Cr -4.6% 12.4% 23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.6%

12.4%

23.2%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses